AIV Logo AIV Assistant

Loading...

 Logo Thermo Fisher Scientific Inc. - TMO 417.99 USD

P/E
38.02
EPS
16.14
Yield
0.40%
P/B
4.94
ROE
13.53
Beta
0.78
Target Price
644.96 USD

417.990 USD

417.990 USD

Daily: +0.00%
Key Metrics

Earnings date: April 22, 2025

P/E: 38.02

EPS: 16.14

Book Value: 124.17

Price to Book: 4.94

Debt/Equity: 74.53

% Insiders: 0.178%

Growth

Revenue Growth: -0.01%

Earnings Growth: 0.15%

Estimates

Forward P/E: 25.69

Forward EPS: 23.89

Target Mean Price: 644.96

Dividend

Dividend Yield: 0.40%

Annual dividends: 1.64 USD

Ex-Div. Date: Sept. 15, 2025

Payout: 9.16%

5y avg Yield: 0.23%

 Logo About Thermo Fisher Scientific Inc. - (TMO)

Country: United States

Sector: Health Care

Website: http://www.thermofisher.com

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Exchange Ticker
BUE (Argentina) TMO.BA
VIE (Austria) TMOF.VI
MEX (Mexico) TMO.MX
SAO (Brazil) TMOS34.SA
FRA (Germany) TN8.F
STU (Germany) TN8.SG
GER (Germany) TN8.DE
NYQ (United States) TMO
Dividend Yield

0.40% (5y avg: 0.23%)

Annual Dividends

1.64 USD

Next ex. div date

Sept. 15, 2025

Payout Ratio

9.16%

Historical Dividends
Year Total Dividends
2026 0.95 USD
2025 2.07 USD
2024 1.91 USD
2023 1.35 USD
2022 1.16 USD
2021 1.00 USD
2020 0.85 USD
2019 0.74 USD
2018 0.66 USD
2017 0.60 USD
2016 0.60 USD
2015 0.60 USD
2014 0.60 USD
2013 0.60 USD
2012 0.39 USD
2001 3.34 USD
1996 0.00 USD
1993 0.04 USD

Yearly aggregated dividends

Dividends

Thermo Fisher Scientific Inc.
Oct 15, 2025 Upcoming
Dividend
0.43 USD
Thermo Fisher Scientific Inc.
Jul 15, 2025 Paid
Dividend
0.43 USD
Thermo Fisher Scientific Inc.
Apr 15, 2025 Paid
Dividend
0.43 USD
Thermo Fisher Scientific Inc.
Dec 13, 2024 Paid
Dividend
0.39 USD
Thermo Fisher Scientific Inc.
Jan 15, 2025 Paid
Dividend
0.39 USD
Thermo Fisher Scientific Inc.
Oct 15, 2024 Paid
Dividend
0.39 USD

Historical Split Corporate Actions

Trades
My Trades
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion